As shown in Table 2, patients with the Y93H mutant strain showed significantly lower ALT levels (p = 8.8 x 10–4), higher serum HCV RNA levels (p = 4.3 x 10–7), and lower HCC risk (p = 6.9 x 10–3) than those with the wild type strain. The gene discussed is GPT; the disease is hepatocellular carcinoma.